Intercept Pharmaceuticals
ICPT
$19.00
Share price
0.00%
Change (1 day)
-7.90%
Change (1 year)
Categories
Earnings for Intercept Pharmaceuticals (ICPT)
Earnings in 2023 (TTM): -$58.01 M
According to Intercept Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$58.01 M. In 2022 the company made an earning of -$0.16 B a decrease over its 2021 earnings that were of -$91.43 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Intercept Pharmaceuticals from 2012 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$58.01 M | -63.57% |
| 2022 | -$0.16 B | 74.17% |
| 2021 | -$91.43 M | -66.74% |
| 2020 | -$0.28 B | -20.25% |
| 2019 | -$0.35 B | 11.46% |
| 2018 | -$0.31 B | -14.19% |
| 2017 | -$0.37 B | -12.71% |
| 2016 | -$0.42 B | 82.32% |
| 2015 | -$0.23 B | -23.21% |
| 2014 | -$0.3 B | 334.95% |
| 2013 | -$67.8 M | 60.48% |
| 2012 | -$42.25 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $6.55 B | -11,399.09% | 🇺🇸 USA |
 Gilead Sciences GILD | $6.85 B | -11,923.82% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $8.44 B | -14,649.22% | 🇺🇸 USA |
 MediciNova MNOV | -$8.57 M | -85.23% | 🇺🇸 USA |